Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity

Authors:

Abstract
No abstract available

This publication has 39 references indexed in Scilit: